Related Experiment Videos
The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils
Y Dang1, G M Lowe, S W Edwards
1University Department of Haematology, Royal Liverpool University Teaching Hospital, U.K.
Abstract:
When purified control neutrophils were primed with GM-CSF, a significant increase in FMLP-induced MPO release was observed (mean +/- S.E.M., 3.4 +/- 0.8 mU/10(7) unprimed cells compared to 6.5 +/- 1.1 mU/10(7) primed cells, p < 0.001). This MPO release was greatly augmented by Cytochalasin B (Cy B), but after the addition of Cy B the priming effects of GM-CSF became less obvious. Exposure to GM-CSF without FMLP did not enhance MPO release. Within whole blood, FMLP produced negligible MPO release, but priming with GM-CSF prior to FMLP always resulted in a significant increase in MPO release. Myelodysplastic neutrophils released similar amounts of MPO in response to FMLP, compared with control cells (3.4 +/- 0.8 mU/10(7) control cells compared to 2.7 +/- 0.3 mU/10(7) MDS cells, p > 0.05). Priming with GM-CSF produced an increase in FMLP-stimulated MPO release comparable with control cells. In terms of total MPO content, although some MDS patients exhibited low levels, as a group there was no significant difference from controls (169 +/- 21 mU/10(7) control cells compared with 157 +/- 19 mU/10(7) MDS cells). These findings suggest that MPO activity is not a universal defect in MDS and cannot account for the defects in respiratory burst activity in these neutrophils.
Insights
Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances neutrophil myeloperoxidase (MPO) release. However, MPO activity is not universally defective in myelodysplastic syndromes (MDS).
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Neutrophils play a crucial role in innate immunity.
- Myeloperoxidase (MPO) is a key enzyme in neutrophil antimicrobial function.
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
Purpose of the Study:
- To investigate the effect of GM-CSF priming on MPO release in neutrophils.
- To assess MPO release and content in neutrophils from MDS patients.
- To determine if MPO activity defects explain impaired respiratory burst in MDS.
Main Methods:
- Neutrophil isolation and purification.
- Priming neutrophils with GM-CSF.
- Stimulation of MPO release using FMLP and Cytochalasin B (Cy B).
- Measurement of MPO release and total MPO content.
- Comparison between control and MDS neutrophils.
Main Results:
- GM-CSF priming significantly increased FMLP-induced MPO release in control neutrophils.
- Cy B augmented MPO release, diminishing the apparent effect of GM-CSF.
- GM-CSF priming enhanced FMLP-stimulated MPO release in whole blood.
- MDS neutrophils showed similar FMLP-induced MPO release compared to controls.
- GM-CSF priming effects on MPO release were comparable in MDS and control neutrophils.
- No significant difference in total MPO content was observed between MDS and control groups.
Conclusions:
- GM-CSF enhances neutrophil MPO release, particularly in whole blood.
- MPO activity is not universally deficient in MDS neutrophils.
- Defects in MPO activity do not account for impaired respiratory burst function in MDS.